Trial Profile
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary) ; Tranexamic acid
- Indications Menorrhagia
- Focus Therapeutic Use
- 25 Jan 2020 Planned End Date changed from 1 Jul 2019 to 17 Jan 2020.
- 25 Jan 2020 Planned initiation date changed from 1 Mar 2018 to 1 Jan 2020.
- 25 Jan 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.